Study S001166

Semaglutide for the Treatment of Opioid Use Disorder: A Pilot Randomized Controlled Trial

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record

Registration

Registration: NCT06639464
Acronym: SHORE
Study type: INTERVENTIONAL
Allocation: RANDOMIZED
Phase: PHASE2
Masking: QUADRUPLE
Status: RECRUITING
Enrollment: 46
Start: 2025-06-02
Primary completion: 2027-09-01
Lead sponsor: Brigham and Women's Hospital
Conditions: Opioid Use Disorder
Interventions: DRUG:Semaglutide; OTHER:Placebo
Results posted: FALSE
Individual participant data sharing: UNDECIDED

Registered primary outcomes

Cue-induced Cravings for Opioids [Baseline, 6 weeks, and 13 weeks after baseline visit]
Relapse to Illicit Opioid Use [Weekly from baseline to end of study at 14 weeks]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.